Llwytho...
Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer’s disease
Phosphodiesterase-9 (PDE9) is a promising target for treatment of Alzheimer’s disease (AD). To discover multifunctional anti-AD agents with capability of PDE9 inhibition and antioxidant activity, a series of novel pyrazolopyrimidinone derivatives, coupling with the pharmacophore of antioxidants such...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Enzyme Inhib Med Chem |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Taylor & Francis
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7011943/ https://ncbi.nlm.nih.gov/pubmed/29271265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2017.1412315 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|